Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Page 39 Page 40 Page 41 Page 42 Page 43 Page 447 ACCP Distinguished Investigator Award Nick Holford, MBChB, FRACP, FAAPS, FISoP – Professor of Clinical Pharmacology, Univ of Auckland, Auckland, New Zealand The Distinguished Investigator Award is given annually and is intended to recognize superior scientific expertise and accomplishments by a senior investigator, usually involving a distinct area of research in basic or clinical pharmacology, for which the individual is internationally known. Dr. Holford has dedicated his career to advancing the science of clinical pharmacology. Some of his key contributions include the development of theory-based approaches such as allometric scaling, greatly aiding pediatric dosing and drug development, clinical trial simulation, disease progression modeling and the development of web-based dosing tools. He is viewed as a key thought leader in the field of clinical pharmacology and pharmacometrics and is a very worthy recipient of the 2017 ACCP Distinguished Investigator Award. ACCP Honorary Fellowship Award Angela DM Kashuba, BScPhm, PharmD, DABCP – John A. and Deborah S. McNeill Jr Distinguished Professor of Pharmacy; Chair, Div of Pharmacotherapy & Experimental Therapeutics, Eshelman School of Pharmacy; Adjunct Professor of Medicine, Dept of Infectious Diseases, Univ of North Carolina at Chapel Hill The Honorary Fellowship Award is given annually to a Non-member of ACCP and is meant to recognize primary activities within the immediate domain of clinical pharmacology. The award recognizes overall contributions to the field, rather than any particular scientific work, by a senior investigator or authority having a national or international reputation in the scientific, public service, legislative, governmental or other area of endeavor impacting the field. Dr. Kashuba has authored over 200 manuscripts and has received over $25 million in research funding. She leads a research group focused on optimizing antiretroviral pharmacology in the treatment, prevention and eradication of HIV infection. She is currently a member of the Advisory Committee for the Office of Research on Women’s Health at the National Inst of Health, making her an outstanding recipient of the 2017 ACCP Honorary Fellowship Award. ng Trends Data Analysis Data Analysis Biosimilars ernative Medicine Individualized Care 2017 ACCP Recognition Award Winners